FACES OF THE FOUNDATION


Every month we feature a "Face of the Foundation." Someone whose involvement in the organization, whether it is through services, support, and/or advocacy, has had a significant impact on the Epilepsy Foundation of Greater Chicago and its mission. This month, we are featuring Jim, long time friend and advocate of the Epilepsy Foundation. He worked at EFGC for over thirty years and we are proud to offer the Jim Davies Scholarship in his honor.

Trevor and Mason

Trevor and Mason


 

 
 

JOIN THE FIGHT

View our latest videos.

EFGC 2014 Walk PSA

walk 2014 psa

Story Days: Charles (Epilepsy Awareness Month) 

cover photo

Join the Fight

YouTube Video

LATEST EFGC NEWS

U.S. Department of Defense Allocates $7.5 million to Epilepsy Research

On July 17, 2014, the U.S. Department of Defense announced that it will allocate $7.5 million to epilepsy research due to the alarming increase of people diagnosed with epilepsy because of Traumatic Brain Injuries sustained in the wars in Iraq and Afghanistan since 2006. This initiative was led by Illinois Senator Dick Durbin and Susan Axelrod of Citizens United for Research in Epilepsy (CURE).

Posted in Home-News, Press Room | Comments closed

2014 Scholarship Winners

The 2014 recipients of the Jim Davies Scholarship were announced at the Epilepsy Foundation of Greater Chicago’s June Board of Directors Meeting. This scholarship is awarded annually in the amount of $1,000 to individuals with epilepsy who will be incoming freshmen to a college or vocational/technical school and will be a full-time student for the 2014/2015 academic school year. Congratulations to the following students for their strong commitment to their education and perseverance in overcoming the obstacles epilepsy may present:

Posted in Home-News, Press Room | Comments closed

Neurosurgeons implant new type of electrical stimulator to control seizures

On June 18, neurosurgeons at the University of Alabama at Birmingham implanted a new type of electrical stimulator to control seizures in patients with difficult-to-control epilepsy. It marked the first time in the Southeast the RNS system by NeuroPace had been implanted since the device gained FDA approval in November 2013. The first patient was a 24-year-old woman from central Alabama.

Posted in Home-News | Comments closed

The Illinois House Passes the Amendment on the Medical Marijuana Law!

The Illinois House passed SB 2636, the medical marijuana law adding epilepsy as a debilitating medical condition,  by a vote of 98-18 on May 21, 2014. This amendment includes epilepsy as one of the conditions for which medical marijuana may be prescribed, and that pediatric intractable cases of epilepsy may be permitted to use cannabis oil in the treatment of childhood seizures. The amendment was passed by the Illinois Senate with a vote of 49-5 on April 2, 2014. 

Posted in Home-News, News | Comments closed

Camp Blackhawk Registration is Now Open!

Registration for Camp Blackhawk 2014 is now open. For the first time, there will be two separate sessions of Camp Blackhawk, giving twice as many kids the chance to participate in this unforgettable event.  These sessions will take place July 13-18, 2014 and August 3-8, 2014 at Red Leaf Village in Ingleside, IL. Up to sixty campers can attend each session of Camp Blackhawk, which is offered free of charge.

Posted in Home-News | Comments closed

Early treatment with AED reduces duration of febrile seizures

New research shows that children with febrile status epilepticus (FSE) who receive earlier treatment with antiepileptic drugs (AEDs) experience a reduction in the duration of the seizure. The study published in Epilepsia, a journal of the International League Against Epilepsy (ILAE), suggests that a standard Emergency Medical Services (EMS) treatment protocol for FSE is needed in the U.S.

Posted in Home-News, Press Room | Comments closed

FDA okays medical device to treat epilepsy

The U.S. Food and Drug Administration has approved a device to help reduce the frequency of seizures in epilepsy patients who have not responded well to medications in the past.

Posted in Home-News | Comments closed